A Preliminary Evaluation of the Toxic Equivalency Factor (TEF) for 2,3,4,7,8-PCDF (4-PCDF) Using Data from the Recent NTP Dioxin Bioassays

PCDD/PCDF toxic equivalency factors (TEFs) are being routinely applied now in human cancer risk assessments for dioxin-like compounds despite the fact that until very recently only two congeners (1,2,3,6,7,8and 1,2,3,7,8,9-hexachlorodibenzo-p-dioxin) other than 2,3,7,8-TCDD had been evaluated for carcinogenicity in a standard cancer bioassay. However, in December 2003, draft reports from the National Toxicology Program (NTP) cancer bioassays were made available for 2,3,7,8-TCDD, 4-PCDF, PCB 126, and a (presumably) equipotent mixture of these three compounds. These data provide important new information for evaluating the accuracy of TEFs in predicting the potential human cancer hazard for 4-PCDF and PCB126 alone and in combination with TCDD. We present herein results from a series of simple statistical tests demonstratting that the current TEF of 0.5 for 4-PCDF, when combined appropriately with the new TCDD bioassay data, fails to predict accurately the results from the new 4-PCDF bioassay.